The JV intends to construct a plant to manufacture non-penicillin and non-cephalosporin Rx drugs and other drugs that are categorised as over-the-counter (OTC) products in Russia. It has also been contemplated to transfer 100 per cent interest in the CJSC Olifen (engaged in production of pharmaceutical substances) being held by Diod to the JV company, subject to due diligence.
1238
1375
7058
0
270
339
7969
15899
950
4999
37792
38000
16000
0
369
699
3698
5289
899
1299
2329
4699
199
399
449
999
9788
19299